| A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields R Chen, NM Sain, KT Harlow, YJ Chen, PK Shires, R Heller, SJ Beebe European Journal of Cancer 50 (15), 2705-2713, 2014 | 98 | 2014 |
| Differential expression of cytokines in the brain and serum during endotoxin tolerance R Chen, H Zhou, J Beltran, L Malellari, SL Chang Journal of neuroimmunology 163 (1-2), 53-72, 2005 | 78 | 2005 |
| Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein HC Adams, R Chen, Z Liu, IP Whitehead Breast Cancer Research 12, 1-15, 2010 | 34 | 2010 |
| Deep learning models for predicting gas adsorption capacity of nanomaterials W Guo, J Liu, F Dong, R Chen, J Das, W Ge, X Xu, H Hong Nanomaterials 12 (19), 3376, 2022 | 26 | 2022 |
| Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells DJ Hoover, V Zhu, R Chen, K Briley, P Rameshwar, S Cohen, FD Coffman PLoS One 8 (5), e62491, 2013 | 22 | 2013 |
| Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression I Tala, R Chen, T Hu, ER Fitzpatrick, DA Williams, IP Whitehead Leukemia 27 (5), 1080-1089, 2013 | 22 | 2013 |
| Evaluating the Use of KIM‐1 in Drug Development and Research Following FDA Qualification R Chen, S Sanyal, A Thompson, JH Ix, K Haskins, L Muldowney, S Amur Clinical Pharmacology & Therapeutics 104 (6), 1175-1181, 2018 | 21 | 2018 |
| Nanosecond pulsed electric field (nsPEF) ablation as an alternative or adjunct to surgery for treatment of cancer R Chen, X Chen, SJ Beebe Surgery: Current Research 12, 2013 | 14 | 2013 |
| Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia R Chen, T Hu, GM Mahon, I Tala, NL Pannucci, HL Ozer, IP Whitehead Blood, The Journal of the American Society of Hematology 122 (12), 2114-2124, 2013 | 8 | 2013 |
| Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery L Xu, R Chen, J Liu, TA Patterson, H Hong Drug Discovery Today, 103727, 2023 | 7 | 2023 |
| Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity NL Pannucci, D Li, S Sahay, EK Thomas, R Chen, I Tala, T Hu, ... Blood Cancer Journal 3 (8), e135-e135, 2013 | 4 | 2013 |
| Common Filing Deficiencies in Abbreviated New Drug Applications Containing Clinical Endpoint Studies LJ Fermaglich, R Chen, CY Kim, EE Chuh, T Thomas, D Shetty, J Lee, ... Therapeutic Innovation & Regulatory Science 53 (1), 81-85, 2019 | 2 | 2019 |
| The ubiquitination-dependent interaction of p210 BCR/ABL with β-catenin contributes to chronic myeloid leukemogenesis R Chen, M Gwen, I Tala, I Whitehead Blood 116 (21), 4186, 2010 | 1 | 2010 |
| Nanosecond pulsed electric field ablation of hepatocellular carcinoma induces regulated cell death and possible immunity SJ Beebe, R Chen, PK Shires, R Heller INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 36, S11-S11, 2015 | | 2015 |
| Investigation Of p210 Bcr-Abl Rhogef Activity In The Progression Of Chronic Myelogenous Leukemia BT Ciccarelli, I Tala, T Hu, D Li, R Chen, Q Chen, IP Whitehead Blood, The Journal of the American Society of Hematology 122 (21), 3802-3802, 2013 | | 2013 |
| Ablation of N1-S1 hepatocellular carcinoma in rat livers with nanosecond pulsed electric fields and induction of protective immunity. R Chen, N Sain, T Harlow, P Shires, G Long, R Heller, S Beebe Cancer Research 73 (8_Supplement), 4753-4753, 2013 | | 2013 |
| Exploring the contribution of ubiquitin binding domain of Bcr-Abl in chronic myelogenous leukemia R Chen, G Mahon, I Tala, Q Chen, T Hu, D Li, H Ozer, I Whitehead Cancer Research 72 (8_Supplement), 2557-2557, 2012 | | 2012 |
| Exploring effects of nanosecond and microsecond pulsed electric field ablation in a rat orthotopic hepatocellular carcinoma model R Chen, NM Sain, SJ Beebe, G Long, P Shires Cancer Research 72 (8_Supplement), 5387-5387, 2012 | | 2012 |
| A p210 BCR/ABL Mutant That Lacks Guanine Nucleotide Exchange Factor Activity Induces Erythroleukemia in a Murine Bone Marrow Transplantation Model I Tala, R Chen, Q Chen, I Whitehead Blood 118 (21), 3756, 2011 | | 2011 |
| Ubiquitin-mediated interaction of p210 Bcr-Abl with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia R Chen, G Mahon, I Tala, I Whitehead Cancer Research 71 (8_Supplement), 936-936, 2011 | | 2011 |
